Monthly
US$200
Billed every month
Sign in to subscribePolyvinyl Alcohol Eye Drops
As of 13 November 2026, for Polyvinyl Alcohol Eye Drops, 24 applications are listed as under review at China's CDE; 12 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 0 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 6 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders0View records ↓
Under-review filings24View records ↓
This year’s generic filers12View records ↓
NHSA approval numbers27View records ↓
API companies with A status8View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 27 distinct approval numbers and 23 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Shijiazhuang Kai Da Bio Gong Cheng Co., Ltd. romanized | 国药准字H20256429 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010100500 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010100600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010101580 | NHSA |
| Suzhou Le Zhu Pharmaceutical Co., Ltd. romanized | 国药准字H20263353 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010101652 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010101791 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265303 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010102763 | NHSA |
| Jilin Ao Dong Pharma Group Yan Ji Co., Ltd. romanized | 国药准字H20253659 | 1.4%(0.4ml: 5.6mg) | Not stated by source | XS01XAJ166G010010103358 | NHSA |
| Zhejiang Sha Pu Ai Si Pharma Co., Ltd. romanized | 国药准字H20253772 | See source | Not stated by source | XS01XAJ166G010010104693 | NHSA |
| Zhen Shi Ming (Jiangxi) Pharma Co., Ltd. romanized | 国药准字H20256412 | 1.4%(0.4ml: 5.6mg) | Not stated by source | XS01XAJ166G010010105387 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20263807 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010105816 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20233854 | 1.4%(10ml:0.14g) | Not stated by source | XS01XAJ166G010010109920 | NHSA |
| Yang Zhou Zhong Bao Pharma Co., Ltd. romanized | 国药准字H20253595 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010181161 | NHSA |
| Xin Dong Sheng Ji Co., Ltd. romanized | 国药准字HC20171010 | 1.4%(0.5ml:7mg) | Not stated by source | XS01XAJ166G010010182468 | NHSA |
| Nanjing Heng Dao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20265635 | 1.4%(0.4ml∶5.6mg) | Not stated by source | XS01XAJ166G010010183035 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20249198 | See source | Not stated by source | XS01XAJ166G010010183150 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010183315 | NHSA |
| Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | 国药准字H20244999 | See source | Not stated by source | XS01XAJ166G010010183383 | NHSA |
| Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized | 国药准字H20254926 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010183562 | NHSA |
| Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254825 | See source | Not stated by source | XS01XAJ166G010010184160 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010184211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249284 | See source | Not stated by source | XS01XAJ166G010010184221 | NHSA |
| Shanghai A Er Fu Si Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249470 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010184738 | NHSA |
| Guo Yao Holding Xin Ye (Hubei) Pharmaceuticals Co., Ltd. romanized | 国药准字H20264596 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010185563 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010200600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010201580 | NHSA |
| Suzhou Le Zhu Pharmaceutical Co., Ltd. romanized | 国药准字H20263353 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010201652 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010201791 | NHSA |
| Jilin Ao Dong Pharma Group Yan Ji Co., Ltd. romanized | 国药准字H20253659 | 1.4%(0.4ml: 5.6mg) | Not stated by source | XS01XAJ166G010010203358 | NHSA |
| Zhen Shi Ming (Jiangxi) Pharma Co., Ltd. romanized | 国药准字H20256412 | 1.4%(0.4ml: 5.6mg) | Not stated by source | XS01XAJ166G010010205387 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20263807 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010205816 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20233855 | 1.4%(10ml:0.14g) | Not stated by source | XS01XAJ166G010010209920 | NHSA |
| Xin Dong Sheng Ji Co., Ltd. romanized | 国药准字HC20171011 | 1.4%(0.5ml:7mg) | Not stated by source | XS01XAJ166G010010282468 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20249198 | See source | Not stated by source | XS01XAJ166G010010283150 | NHSA |
| Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | 国药准字H20244999 | See source | Not stated by source | XS01XAJ166G010010283383 | NHSA |
| Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254825 | See source | Not stated by source | XS01XAJ166G010010284160 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010284211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249284 | See source | Not stated by source | XS01XAJ166G010010284221 | NHSA |
| Shanghai A Er Fu Si Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249470 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010284738 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010300600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010301580 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010301791 | NHSA |
| Zhen Shi Ming (Jiangxi) Pharma Co., Ltd. romanized | 国药准字H20256412 | 1.4%(0.4ml: 5.6mg) | Not stated by source | XS01XAJ166G010010305387 | NHSA |
| Xin Dong Sheng Ji Co., Ltd. romanized | 国药准字HC20171011 | 1.4%(0.5ml:7mg) | Not stated by source | XS01XAJ166G010010382468 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20249198 | See source | Not stated by source | XS01XAJ166G010010383150 | NHSA |
| Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | 国药准字H20244999 | See source | Not stated by source | XS01XAJ166G010010383383 | NHSA |
| Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254825 | See source | Not stated by source | XS01XAJ166G010010384160 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010384211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249284 | See source | Not stated by source | XS01XAJ166G010010384221 | NHSA |
| Shanghai A Er Fu Si Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249470 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010384738 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010400600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010401580 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010401791 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20249198 | See source | Not stated by source | XS01XAJ166G010010483150 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010484211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249284 | See source | Not stated by source | XS01XAJ166G010010484221 | NHSA |
| Shanghai A Er Fu Si Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249470 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010484738 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010500600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010501580 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010501791 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20249198 | See source | Not stated by source | XS01XAJ166G010010583150 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010584211 | NHSA |
| Shanghai A Er Fu Si Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249470 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010584738 | NHSA |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H20253649 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010600600 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010010601580 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010010601791 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254877 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010010684211 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010011783315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010011883315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010011983315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012083315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012183315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012283315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012383315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012483315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012583315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012683315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012783315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012883315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010012983315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010013083315 | NHSA |
| Zhong Shan Wan Yuan Xin Yao Research and Development Co., Ltd. romanized | 国药准字H20258060 | 1.4%(0.4ml:5.6mg) | Not stated by source | XS01XAJ166G010013183315 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010020101580 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20253921 | 1.4%(15ml:0.21g) | Not stated by source | XS01XAJ166G010020183150 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010020201580 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010020301580 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010020401580 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010020501580 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010030101580 | NHSA |
| You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | 国药准字H20183006 | See source | Not stated by source | XS01XAJ166G010030201580 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20064930 | 0.4ml:5.6mg | Not stated by source | XS01XAJ166G010040101791 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20064930 | 0.4ml:5.6mg | Not stated by source | XS01XAJ166G010040201791 | NHSA |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20046681 | 0.8ml:11.2mg | Not stated by source | XS01XAJ166G010050101791 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 24 filings and 21 distinct first applicants.
Generic 22 · Supplement 2
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2601284 | Generic | 2026/06/03 | Not stated by source | CDE |
| Hubei Min Kang Pharma Group Co., Ltd. romanized; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2504019 | Generic | 2025/11/20 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2601892 | Generic | 2026/08/04 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2600633 | Generic | 2026/03/10 | Not stated by source | CDE |
| Hefei Li Min Pharmaceutical Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2601754 | Generic | 2026/07/22 | Not stated by source | CDE |
| Hefei Nuo Rui Te Pharmaceutical Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2601733 | Generic | 2026/07/20 | Not stated by source | CDE |
| Sichuan Hao Yi Sheng Pan Xi Pharma Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2600570 | Generic | 2026/02/27 | Not stated by source | CDE |
| Shandong He Qi Pharmaceutical Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2602300 | Generic | 2026/09/16 | Not stated by source | CDE |
| Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kang Ya Pharma Co., Ltd. romanized | CYHB2601154 | Supplement | 2026/06/18 | Not stated by source | CDE |
| Shanghai Xiao Fang Pharmaceutical Co., Ltd. romanized; Zhi He (Shandong) Da Pharmaceutical Factory Co., Ltd. romanized | CYHS2600963 | Generic | 2026/04/25 | Not stated by source | CDE |
| Man Xiu Lei Dun (Zhongguo) Pharma Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2600623 | Generic | 2026/03/06 | Not stated by source | CDE |
| Sichuan Hao Yi Sheng Pan Xi Pharma Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2600571 | Generic | 2026/02/27 | Not stated by source | CDE |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized; Jin Yao Yong Guang (Hebei) Pharmaceutical Co., Ltd. romanized | CYHS2600009 | Generic | 2026/01/05 | Not stated by source | CDE |
| Sichuan He Yi Pharmaceutical Co., Ltd. romanized | CYHS2503987 | Generic | 2025/11/18 | Not stated by source | CDE |
| Chengdu Pusch Pharmaceutical Co., Ltd. | CYHS2503978 | Generic | 2025/11/18 | Not stated by source | CDE |
| Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | CYHS2503806 | Generic | 2025/10/28 | Not stated by source | CDE |
| Guangzhou Da Guang Pharmaceutical Co., Ltd. romanized | CYHS2503480 | Generic | 2025/09/20 | Not stated by source | CDE |
| Shandong Bo Shi Lun Fu Rui Da Pharmaceutical Co., Ltd. romanized | CYHS2502798 | Generic | 2025/08/02 | Not stated by source | CDE |
| Rui Hai Pharmaceuticals Technology (Shandong) Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2502218 | Generic | 2025/06/20 | Not stated by source | CDE |
| Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2602689 | Generic | 2026/11/04 | Not stated by source | CDE |
| Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized | CYHB2650216 | Supplement | 2026/11/06 | Not stated by source | CDE |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2602753 | Generic | 2026/11/09 | Not stated by source | CDE |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2602752 | Generic | 2026/11/09 | Not stated by source | CDE |
| Guangdong Da Peng Pharma Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2602800 | Generic | 2026/11/12 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 15 filings and 12 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2601284 | Generic | 2026/06/03 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2601892 | Generic | 2026/08/04 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2600633 | Generic | 2026/03/10 | Not stated by source | CDE |
| Hefei Li Min Pharmaceutical Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2601754 | Generic | 2026/07/22 | Not stated by source | CDE |
| Hefei Nuo Rui Te Pharmaceutical Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2601733 | Generic | 2026/07/20 | Not stated by source | CDE |
| Sichuan Hao Yi Sheng Pan Xi Pharma Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2600570 | Generic | 2026/02/27 | Not stated by source | CDE |
| Shandong He Qi Pharmaceutical Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2602300 | Generic | 2026/09/16 | Not stated by source | CDE |
| Shanghai Xiao Fang Pharmaceutical Co., Ltd. romanized; Zhi He (Shandong) Da Pharmaceutical Factory Co., Ltd. romanized | CYHS2600963 | Generic | 2026/04/25 | Not stated by source | CDE |
| Man Xiu Lei Dun (Zhongguo) Pharma Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2600623 | Generic | 2026/03/06 | Not stated by source | CDE |
| Sichuan Hao Yi Sheng Pan Xi Pharma Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2600571 | Generic | 2026/02/27 | Not stated by source | CDE |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized; Jin Yao Yong Guang (Hebei) Pharmaceutical Co., Ltd. romanized | CYHS2600009 | Generic | 2026/01/05 | Not stated by source | CDE |
| Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2602689 | Generic | 2026/11/04 | Not stated by source | CDE |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized | CYHS2602753 | Generic | 2026/11/09 | Not stated by source | CDE |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2602752 | Generic | 2026/11/09 | Not stated by source | CDE |
| Guangdong Da Peng Pharma Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CYHS2602800 | Generic | 2026/11/12 | Not stated by source | CDE |
API registrations
Non-component matches: 8 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 聚乙烯醇 · No verified English name | Guangdong Xian Qiang Pharma Co., Ltd. romanized | Y20240000527 | A | Exact ingredient | 2025/10/27 | CDE |
| 聚乙烯醇 · No verified English name | Zhuhai Lian Bang Pharmaceutical Co., Ltd. romanized | Y20230000708 | A | Exact ingredient | 2025/03/26 | CDE |
| 聚乙烯醇 · No verified English name | Shanxi Yang He Pharma Co., Ltd. romanized | Y20230000422 | A | Exact ingredient | 2026/02/26 | CDE |
| 聚乙烯醇 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20220000420 | A | Exact ingredient | 2026/01/29 | CDE |
| 聚乙烯醇 · No verified English name | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Y20210000920 | A | Exact ingredient | 2025/10/27 | CDE |
| 聚乙烯醇 · No verified English name | Zhejiang Sha Pu Ai Si Pharma Co., Ltd. romanized | Y20210000413 | A | Exact ingredient | 2023/03/29 | CDE |
| 聚乙烯醇 · No verified English name | Hubei Hua Dan Pharmaceuticals Technology Co., Ltd. romanized | Y20190008621 | A | Exact ingredient | 2025/08/12 | CDE |
| 聚乙烯醇 · No verified English name | Wuhan Wu Yao Pharmaceutical Co., Ltd. romanized | Y20170000148 | A | Exact ingredient | 2025/01/25 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/12Accepted
Guangdong Da Peng Pharma Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized
CYHS2602800
Fact date: 2026/11/12 · Site observation date: 2026/11/13
View source ↗ -
2026/11/11No longer listed under review
HUNAN WARRANT PHARMACEUTICAL CO.,LTD
CYHS2501941
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/05/31
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/09Accepted
Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized
CYHS2602753
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/09Accepted
Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized
CYHS2602752
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/06Accepted
Hubei Yuan Da Tian Tian Ming Pharmaceutical Co., Ltd. romanized
CYHB2650216
Fact date: 2026/11/06 · Site observation date: 2026/11/07
View source ↗ -
2026/11/04Accepted
Hefei Hua Wei Pharma Co., Ltd. romanized
CYHS2602689
Fact date: 2026/11/04 · Site observation date: 2026/11/05
View source ↗ -
2026/10/26Marketing application approved
Hefei Li Min Pharmaceutical Co., Ltd. romanized
CYHS2502433 · 国药准字H20266399
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 53 ↗ -
2026/09/16Accepted
Shandong He Qi Pharmaceutical Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized
CYHS2602300
Fact date: 2026/09/16 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Polyvinyl Alcohol Eye Drops
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy